13F-HR filed by venBio Partners LLC
venBio Partners LLC filed this 13F-HR for the quarter ended 2020-09-30, filed 2020-11-16, with 8 holding rows worth $658,029,000.
- Accession
- 0001567619-20-019877
- Filer
- CIK 1776382
- Filed
- 2020-11-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2020
A holdings report, 8 entries on the cover page, a total value of $658,029,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $658,029,000 with VALUE read as thousands by filing date, 13F file number 028-19529. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 9,699,925 | $366,075,000 | thousands by filing date | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 3,504,624 | $118,807,000 | thousands by filing date | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 2,444,311 | $75,260,000 | thousands by filing date | |
| CHECKMATE PHARMACEUTICALS IN | 162818108 | COM | 3,673,374 | $42,281,000 | thousands by filing date | |
| METACRINE INC | 59101E103 | COM | 3,059,123 | $31,234,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 501,584 | $15,133,000 | thousands by filing date | |
| PRECISION BIOSCIENCES INC | 74019P108 | COM | 1,298,191 | $7,997,000 | thousands by filing date | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 199,075 | $1,242,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001567619-20-019877 | this filing | 2020-11-16 | acceptance time not in the bulk data set |